KATHARINE JONES: Open Payments
NPI 1497197651 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 41 payments from 8 companies in 2025. Trend: 2023 $450 · 2024 $304 · 2025 $590
Food & beverage: $510Education: $80
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 13 | $227 |
| Lilly USA, LLC | 16 | $131 |
| Novo Nordisk Inc | 5 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| ViiV Healthcare Company | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: GEMTESA, MOUNJARO, Wegovy, JARDIANCE, Ozempic, MYFEMBREE, Auvelity, APRETUDE.
Industry payments across TX — which companies pay providers there.
